Note:
1) see Section 2.3 for study criteria (patient enrollment requirements);
2) .... acquisition of tumour specimens both before study therapy is
started and after neoadjuvant chemotherapy has been received provides a
unique opportunity for a correlative study of differing drug responses
within the same patients.
Although the study is led by the ncic ctg,
the protocol, the accompanying IP therapy guidelines, and a companion
document intended to summarize and promote best practice in the
administration of IP therapy are the result of a collaboration between
the ncic ctg and the Society of
Gynecologic Oncologists of Canada, with international partners in the
United Kingdom (National Cancer Research Institute), Spain (Spanish
Ovarian Cancer Research Group), and the United States (Southwest
Oncology Group).
Abstract: (including full free text access):